Avelumab is an anti-PD-L1 Monoclonal Antibody for Cancer research
PD-1/PD-L1, refers to immune checkpoint programmed cell death protein 1 (PD-1) and its main ligand, Programmed death ligand 1. Linked to multiple cancer types. PD-L1 is mainly expressed on a…